Ronen Ben‐Ami
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antifungal resistance and susceptibility 62
- Antimicrobial Resistance in Staphylococcus 9
- SARS-CoV-2 and COVID-19 Research 8
- Epidemiology 66
- Fungal Infections and Studies 41
- Pneumocystis jirovecii pneumonia detection and treatment 12
- Nail Diseases and Treatments 8
- Co-authors
- Dimitrios P. Kontoyiannis (29 shared papers)Russell E. Lewis (23 shared papers)Yehuda Carmeli (8 shared papers)Shiri Navon‐Venezia (7 shared papers)David A. Schwartz (6 shared papers)Mitchell J. Schwaber (4 shared papers)Konstantinos Leventakos (7 shared papers)Michael Giladi (7 shared papers)
- Journals
- Clinical Infectious Diseases (8 papers)Journal of Fungi (7 papers)Antimicrobial Agents and Chemotherapy (7 papers)Mycoses (7 papers)Clinical Microbiology and Infection (7 papers)
- Partner nations
- IsraelUnited StatesChina
In The Last Decade
Ronen Ben‐Ami
155 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 129
- Applied Microbiology and Biotechnology 351
- Molecular Medicine 933
- Infectious Diseases 2.7k
- Epidemiology 2.1k
- Endocrinology 304
Countries citing papers authored by Ronen Ben‐Ami
This map shows the geographic impact of Ronen Ben‐Ami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronen Ben‐Ami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronen Ben‐Ami more than expected).
Fields of papers citing papers by Ronen Ben‐Ami
This network shows the impact of papers produced by Ronen Ben‐Ami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronen Ben‐Ami. The network helps show where Ronen Ben‐Ami may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronen Ben‐Ami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 393 | |
| 2 | 2006 | 343 | |
| 3 | 2006 | 263 | |
| 4 | 2017 | 259 | |
| 5 | 2005 | 207 | |
| 6 | 2013 | 202 | |
| 7 | 2021 | 173 | |
| 8 | 2012 | 146 | |
| 9 | 2011 | 129 | |
| 10 | 2021 | 128 | |
| 11 | 2008 | 114 | |
| 12 | 2010 | 107 | |
| 13 | 2005 | 104 | |
| 14 | 2009 | 103 | |
| 15 | 2009 | 100 | |
| 16 | 2009 | 98 | |
| 17 | 2021 | 95 | |
| 18 | 2009 | 91 | |
| 19 | 2018 | 87 | |
| 20 | 2007 | 82 |
About Ronen Ben‐Ami
Ronen Ben‐Ami is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Oncology and Immunology, having authored 160 papers that have together received 5.6k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (62 papers), Fungal Infections and Studies (41 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotic Resistance in Bacteria (8 papers), Nail Diseases and Treatments (8 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Antibiotic Use and Resistance (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (351 citations), Molecular Medicine (933 citations), Infectious Diseases (2.7k citations), Epidemiology (2.1k citations) and Endocrinology (304 citations). Ronen Ben‐Ami has collaborated with scholars based in Israel, United States and China. Frequent co-authors include Dimitrios P. Kontoyiannis, Russell E. Lewis, Yehuda Carmeli, Shiri Navon‐Venezia, David A. Schwartz, Mitchell J. Schwaber, Konstantinos Leventakos, Michael Giladi, Keith S. Kaye and Saul Yedgar. Their work appears in journals such as Clinical Infectious Diseases, Journal of Fungi, Antimicrobial Agents and Chemotherapy, Mycoses and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.